Rhinovirus-Induced Shutoff of Cellular Responses
Rhinovirus-Induced Shutoff of Cellular Responses
批准号:
7151335
负责人:
ANN C. PALMENBERG
金额:
$16.82万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2011-08-31
关键词:
HeLa cellsasthmacell typecellular pathologycooperative studycytolysisendopeptidasesenzyme activitygenetic transcriptiongenetic translationgenotypehost organism interactionhuman genetic material taghuman tissueimmune responselaboratory mouselaboratory rabbitnuclear transportpathologic processphenotyperespiratory infectionsrespiratory virusrhinovirustissue /cell culturevirus geneticsvirus infection mechanismvirus proteinvirus replication
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The RNA picornaviruses have evolved wonderfully robust and effective mechanisms to express their
proteins and override host defenses. Novel internal ribosomal entry sites (IRESs) allow these genomes to
bypass normal translational requirements for 5' cap structures and efficiently lure the ribosomes into viral
instead of cellular pathways. The captured ribosomes pass down a single, long open reading frame (ORF),
creating polyproteins that are in reality, tandem linkages of all structural and enzymatic units necessary for
rapid and virulent infection. Individual protein fragments are liberated co-translationally and posttranslationally
in an elaborate proteolytic cascade that is a defining feature of this family. The molecular
biology of picornaviruses, and in particular that of poliovirus and the closely related human rhinovirus, is
perhaps one of the best understood and most thoroughly accessible experimental systems in all of biology.
Basic mechanisms of IRES translation, protein processing or genome replication have been under
investigation for decades and there are superb molecular and recombinant tools available for the study of
every aspect of the virus lifecycle. The focus of this project is the way in which the human rhinoviruses can
seditiously subvert a cell's innate immunity traps, crippling the capacity of that cell to trigger an alarm or
altering the nature of the alarm itself. The molecular battleground in that first infected cell, pits two key viral
proteases, 2Apro and 3Cpro, enzymes strategically honed by evolution for this particular purpose, against
cellular defenses that may vary significantly according to cell-type, cell-cycle, host genetics, immune history
and current medical predisposition. We propose that substantially different disease phenotypes can be
triggered at their core, by the ability or inability of these proteases to shutoff of crucial cellular transcription
and translational processes. Every subsequent immune and disease response is consequent to this
outcome. At the ultimate molecular level, the activities of these proteases instigate the cascade of events
that set off or prevent an episode of disease. The experiments in this project will examine the cleavage
processes and molecular consequences by which rhinovirus infection inactivates cytoplasmic-nuclear
transport, thus crippling the ability of the cell to carry out mRNA transcription, or cap-dependent translation.
They will determine whether an unconditional viral-induced shutoff of nuclear transport is necessary to allow
viral replication and cell lysis. Or, under conditions when these processes are only partially effective, whether
a host-induced up-regulation of innate triggers then quickly escalates into a full-blown immune response, that
may or may not be inappropriate for the extent and severity of actual infection. The project will also examine
host shutoff activities are ubiquitous and similar in multiple human cell types, or are modulated by the
genetics and/or innate immunity status of the cultures and the genotype of virus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying Coronavirus B-cell Epitopes Associated with COVID-19 Illness Severity
-
批准号:10201317
-
项目类别:
-
资助金额:$40.6万
-
财政年份:2020
-
负责人:ANN C. PALMENBERG
-
依托单位:
Molecular Biology of RV-C and its Asthma-related Receptor, CDHR3
-
批准号:10327681
-
项目类别:
-
资助金额:$40.35万
-
财政年份:2020
-
负责人:ANN C. PALMENBERG
-
依托单位:
Molecular Biology of RV-C and its Asthma-related Receptor, CDHR3
-
批准号:10440067
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2013
-
负责人:ANN C. PALMENBERG
-
依托单位:
COMPARATIVE MOLECULAR BIOLOGY AND GENOME STRUCTURE OF HRV-C
-
批准号:8469998
-
项目类别:
-
资助金额:$21.38万
-
财政年份:2013
-
负责人:ANN C. PALMENBERG
-
依托单位:
Molecular Biology of RV-C and its Asthma-related Receptor, CDHR3
-
批准号:10091396
-
项目类别:
-
资助金额:$53.35万
-
财政年份:2013
-
负责人:ANN C. PALMENBERG
-
依托单位:
VISUALIZATION OF VIRUS INFECTED CELLS
-
批准号:6117320
-
项目类别:
-
资助金额:$1.13万
-
财政年份:1998
-
负责人:ANN C. PALMENBERG
-
依托单位:
RELOCALIZATION OF CELLULAR PKR DURING MENGO VIRUS INFECTION
-
批准号:6117330
-
项目类别:
-
资助金额:$1.13万
-
财政年份:1998
-
负责人:ANN C. PALMENBERG
-
依托单位:
VISUALIZATION OF VIRUS INFECTED CELLS
-
批准号:6278515
-
项目类别:
-
资助金额:$0.04万
-
财政年份:1998
-
负责人:ANN C. PALMENBERG
-
依托单位:
RELOCALIZATION OF CELLULAR PKR DURING MENGO VIRUS INFECTION
-
批准号:6278525
-
项目类别:
-
资助金额:$0.01万
-
财政年份:1998
-
负责人:ANN C. PALMENBERG
-
依托单位:
VISUALIZATION OF VIRUS INFECTED CELLS
-
批准号:6248556
-
项目类别:
-
资助金额:$0.77万
-
财政年份:1997
-
负责人:ANN C. PALMENBERG
-
依托单位:
CARDIOVIRAL POLY-C TRACTS AND VIRUS PATHOGENICITY
-
批准号:2065726
-
项目类别:
-
资助金额:$16.67万
-
财政年份:1991
-
负责人:ANN C. PALMENBERG
-
依托单位:
CARDIOVIRAL POLY (C) TRACTS AND VIRUS PATHOGENICITY
-
批准号:2667715
-
项目类别:
-
资助金额:$18.59万
-
财政年份:1991
-
负责人:ANN C. PALMENBERG
-
依托单位:
CARDIOVIRAL POLY(C) TRACTS AND VIRUS PATHOGENICITY
-
批准号:3145609
-
项目类别:
-
资助金额:$15.65万
-
财政年份:1991
-
负责人:ANN C. PALMENBERG
-
依托单位:
CARDIOVIRAL POLY-C TRACTS AND VIRUS PATHOGENICITY
-
批准号:2065725
-
项目类别:
-
资助金额:$15.68万
-
财政年份:1991
-
负责人:ANN C. PALMENBERG
-
依托单位:
CARDIOVIRAL POLY(C) TRACTS AND VIRUS PATHOGENICITY
-
批准号:3145608
-
项目类别:
-
资助金额:$15.55万
-
财政年份:1991
-
负责人:ANN C. PALMENBERG
-
依托单位:
CARDIOVIRAL POLY (C) TRACTS AND VIRUS PATHOGENICITY
-
批准号:2003636
-
项目类别:
-
资助金额:$18.33万
-
财政年份:1991
-
负责人:ANN C. PALMENBERG
-
依托单位:
CARDIOVIRAL POLY (C) TRACTS AND VIRUS PATHOGENICITY
-
批准号:2882165
-
项目类别:
-
资助金额:$19.15万
-
财政年份:1991
-
负责人:ANN C. PALMENBERG
-
依托单位:
CARDIOVIRAL POLY (C) TRACTS AND VIRUS PATHOGENICITY
-
批准号:6163872
-
项目类别:
-
资助金额:$19.72万
-
财政年份:1991
-
负责人:ANN C. PALMENBERG
-
依托单位:
CARDIOVIRAL POLY(C) TRACTS AND VIRUS PATHOGENICITY
-
批准号:3145607
-
项目类别:
-
资助金额:$18.4万
-
财政年份:1991
-
负责人:ANN C. PALMENBERG
-
依托单位:
CARDIOVIRAL PROTEASES AND COMPARATIVE GENOME STRUCTURE
-
批准号:2060497
-
项目类别:
-
资助金额:$18.25万
-
财政年份:1980
-
负责人:ANN C. PALMENBERG
-
依托单位:
国内基金
海外基金
大鱼际掌纹特应征与5个哮喘易感基因单核苷酸多态性的关联分析
-
批准号:30873315
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:周兆山
-
依托单位:
调节性T细胞和共刺激分子在过敏原早期暴露诱导哮喘免疫耐受中的作用机制研究
-
批准号:30740048
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2007
-
负责人:李海潮
-
依托单位:
CBP介导STAT4/STAT6相互拮抗在哮喘Th失衡中的机制
-
批准号:30672268
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2006
-
负责人:符州
-
依托单位: